The relevance between anti-rods/rings antibody and different treatment regimens in chronic hepatitis C virus infection.

Peker, Bilal Olcay; Sener, Asli Gamze; Topal, Firdevs; Saritas Yüksel, Elif

Peker, Bilal Olcay; Sener, Asli Gamze; Topal, Firdevs; Saritas Yüksel, Elif.

Afiliación

Peker BO; Department of Medical Microbiology, Izmir Katip Çelebi University Atatürk Training And Research Hospital, Izmir, Turkey.
Sener AG; Department of Medical Microbiology, Izmir Katip Çelebi University Atatürk Training And Research Hospital, Izmir, Turkey.
Topal F; Department of Gastroenterology, Izmir Katip Çelebi University Medical Faculty, Izmir, Turkey.
Saritas Yüksel E; Department of Gastroenterology, Izmir Katip Çelebi University Medical Faculty, Izmir, Turkey.

Microbiol Immunol ; 65(4): 171-177, 2021 Apr.

Article en En | MEDLINE | ID: mdl-33538354

Asunto(s)

Anticuerpos Antinucleares/inmunología; Antivirales; Anticuerpos Antihepatitis/inmunología; Hepatitis C Crónica; Antivirales/uso terapéutico; Genotipo; Hepacivirus; Hepatitis C Crónica/tratamiento farmacológico; Humanos; Polietilenglicoles; Proteínas Recombinantes; Ribavirina/uso terapéutico; Resultado del Tratamiento

Palabras clave

anti-rods/rings; direct-acting antivirals; hepatitis C virus; pegylated IFN-alpha

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Anticuerpos Antihepatitis / Anticuerpos Antinucleares / Hepatitis C Crónica Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Microbiol Immunol Año: 2021 Tipo del documento: Article País de afiliación: Turquía

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google